Rayno Biopharmaceutical Stocks-CBST Up 35%

Update 12/8

Biotech stocks hit new highs yesterday but could get choppy if overall market gets weak on bleak macro news.

Cubist Pharmaceuticals (CBST) one of our original mid cap Biopharmaceutical picks soared 35% today to $100.75 on a $8.4B buyout by Merck (MRK).

 

No comments yet.

Leave a Reply